Patents by Inventor Eva-lotte Alstermark Lindstedt

Eva-lotte Alstermark Lindstedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor ? (PPAR)
    Patent number: 7514471
    Abstract: The present invention provides the S enantiomer of a compound of formula (I) wherein n is 1 or 2 as well as pharmaceutically acceptable salts, solvates, crystalline forms and prodrugs thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: April 7, 2009
    Assignee: AstraZeneca AB
    Inventors: Eva-Lotte Alstermark Lindstedt, Anna Christina Olsson, Lanna Li
  • 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
    Patent number: 7276539
    Abstract: A compound of formula I wherein R1 represents chloro, fluoro or hydroxy as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, prodrugs, solvates and crystalline forms thereof, processes for preparing such compounds, their utility in treating clinical conditions associated with insulin resistance, methods for their therapeutic use and pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: October 2, 2007
    Assignee: AstraZeneca AB
    Inventors: Eva-Lotte Alstermark Lindstedt, Anna Maria Persdotter Boije, Patrick Holm
  • Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor ?(PPAR)
    Patent number: 7256307
    Abstract: The present invention provides the S enantiomer of a compound of formula (I); wherein R1 represents 2,4-difluorophenyl or cyclohexyl as well as pharmaceutically acceptable salts, solvates, crystalline forms and prodrugs thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: August 14, 2007
    Assignee: AstraZeneca AB
    Inventors: Eva-lotte Alstermark Lindstedt, Anna Christina Olsson, Lanna Li
  • 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
    Publication number: 20050215630
    Abstract: A compound of formula (I); wherein R1 represents chloro, fluoro or hydroxy as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, prodrugs, solvates and crystalline forms thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: December 18, 2002
    Publication date: September 29, 2005
    Applicant: AstraZeneca Ab
    Inventors: Eva-Lotte Alstermark Lindstedt, Anna Boije, Patrick Holm